These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 14722920)

  • 41. Loss of GABAergic cortical neurons underlies the neuropathology of Lafora disease.
    Ortolano S; Vieitez I; Agis-Balboa RC; Spuch C
    Mol Brain; 2014 Jan; 7():7. PubMed ID: 24472629
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activation of serum/glucocorticoid-induced kinase 1 (SGK1) underlies increased glycogen levels, mTOR activation, and autophagy defects in Lafora disease.
    Singh PK; Singh S; Ganesh S
    Mol Biol Cell; 2013 Dec; 24(24):3776-86. PubMed ID: 24131995
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Laforin is a cell membrane and endoplasmic reticulum-associated protein tyrosine phosphatase.
    Minassian BA; Andrade DM; Ianzano L; Young EJ; Chan E; Ackerley CA; Scherer SW
    Ann Neurol; 2001 Feb; 49(2):271-5. PubMed ID: 11220751
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Glycogen metabolism in tissues from a mouse model of Lafora disease.
    Wang W; Lohi H; Skurat AV; DePaoli-Roach AA; Minassian BA; Roach PJ
    Arch Biochem Biophys; 2007 Jan; 457(2):264-9. PubMed ID: 17118331
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regional and developmental expression of Epm2a gene and its evolutionary conservation.
    Ganesh S; Agarwala KL; Amano K; Suzuki T; Delgado-Escueta AV; Yamakawa K
    Biochem Biophys Res Commun; 2001 May; 283(5):1046-53. PubMed ID: 11355878
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Exploring the structural insights on human laforin mutation K87A in Lafora disease--a molecular dynamics study.
    Srikumar PS; Rohini K
    Appl Biochem Biotechnol; 2013 Oct; 171(4):874-82. PubMed ID: 23904258
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mutations in the NHLRC1 gene are the common cause for Lafora disease in the Japanese population.
    Singh S; Suzuki T; Uchiyama A; Kumada S; Moriyama N; Hirose S; Takahashi Y; Sugie H; Mizoguchi K; Inoue Y; Kimura K; Sawaishi Y; Yamakawa K; Ganesh S
    J Hum Genet; 2005; 50(7):347-352. PubMed ID: 16021330
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mutation screening for Japanese Lafora's disease patients: identification of novel sequence variants in the coding and upstream regulatory regions of EPM2A gene.
    Ganesh S; Shoda K; Amano K; Uchiyama A; Kumada S; Moriyama N; Hirose S; Yamakawa K
    Mol Cell Probes; 2001 Oct; 15(5):281-9. PubMed ID: 11735300
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Deciphering the role of malin in the lafora progressive myoclonus epilepsy.
    Romá-Mateo C; Sanz P; Gentry MS
    IUBMB Life; 2012 Oct; 64(10):801-8. PubMed ID: 22815132
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatic disease as the first manifestation of progressive myoclonus epilepsy of Lafora.
    Gómez-Garre P; Gutiérrez-Delicado E; Gómez-Abad C; Morales-Corraliza J; Villanueva VE; Rodríguez de Córdoba S; Larrauri J; Gutiérrez M; Berciano J; Serratosa JM
    Neurology; 2007 Apr; 68(17):1369-73. PubMed ID: 17452581
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lafora disease proteins laforin and malin negatively regulate the HIPK2-p53 cell death pathway.
    Upadhyay M; Gupta S; Bhadauriya P; Ganesh S
    Biochem Biophys Res Commun; 2015 Aug; 464(1):106-11. PubMed ID: 26102034
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A bioassay for Lafora disease and laforin glucan phosphatase activity.
    Sherwood AR; Johnson MB; Delgado-Escueta AV; Gentry MS
    Clin Biochem; 2013 Dec; 46(18):1869-76. PubMed ID: 24012855
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interdependence of laforin and malin proteins for their stability and functions could underlie the molecular basis of locus heterogeneity in Lafora disease.
    Mittal S; Upadhyay M; Singh PK; Parihar R; Ganesh S
    J Biosci; 2015 Dec; 40(5):863-71. PubMed ID: 26648032
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protein degradation and quality control in cells from laforin and malin knockout mice.
    Garyali P; Segvich DM; DePaoli-Roach AA; Roach PJ
    J Biol Chem; 2014 Jul; 289(30):20606-14. PubMed ID: 24914213
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Laforin and malin deletions in mice produce similar neurologic impairments.
    García-Cabrero AM; Marinas A; Guerrero R; de Córdoba SR; Serratosa JM; Sánchez MP
    J Neuropathol Exp Neurol; 2012 May; 71(5):413-21. PubMed ID: 22487859
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy.
    Minassian BA; Lee JR; Herbrick JA; Huizenga J; Soder S; Mungall AJ; Dunham I; Gardner R; Fong CY; Carpenter S; Jardim L; Satishchandra P; Andermann E; Snead OC; Lopes-Cendes I; Tsui LC; Delgado-Escueta AV; Rouleau GA; Scherer SW
    Nat Genet; 1998 Oct; 20(2):171-4. PubMed ID: 9771710
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Loss of laforin or malin results in increased Drp1 level and concomitant mitochondrial fragmentation in Lafora disease mouse models.
    Upadhyay M; Agarwal S; Bhadauriya P; Ganesh S
    Neurobiol Dis; 2017 Apr; 100():39-51. PubMed ID: 28063983
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Insights into Lafora disease: malin is an E3 ubiquitin ligase that ubiquitinates and promotes the degradation of laforin.
    Gentry MS; Worby CA; Dixon JE
    Proc Natl Acad Sci U S A; 2005 Jun; 102(24):8501-6. PubMed ID: 15930137
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lafora progressive Myoclonus Epilepsy mutation database-EPM2A and NHLRC1 (EPM2B) genes.
    Ianzano L; Zhang J; Chan EM; Zhao XC; Lohi H; Scherer SW; Minassian BA
    Hum Mutat; 2005 Oct; 26(4):397. PubMed ID: 16134145
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Laforin, a dual-specificity phosphatase involved in Lafora disease, is phosphorylated at Ser25 by AMP-activated protein kinase.
    Romá-Mateo C; Solaz-Fuster Mdel C; Gimeno-Alcañiz JV; Dukhande VV; Donderis J; Worby CA; Marina A; Criado O; Koller A; Rodriguez De Cordoba S; Gentry MS; Sanz P
    Biochem J; 2011 Oct; 439(2):265-75. PubMed ID: 21728993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.